• Explore /
  • Poster
  • / A study of senaparib in combination with temozolomide for the treatment of patients with advanced solid tumors and extensive-stage small cell lung cancer.

A study of senaparib in combination with temozolomide for the treatment of patients with advanced solid tumors and extensive-stage small cell lung cancer.

Abstract Poster

Authors

null

Bo Gao

Blacktown Cancer & Haematology Centre, Blacktown Hospital, Sydney, NSW, Australia

Bo Gao , Chia-Chi Lin , Li-Yuan Bai , Wei-Pang Chung , Wan-Chen Kao , Robert Zielinski , Byoung Yong Shim , Min Hee Hong , Sang-We Kim , Chien-Ying Liu , Chih-Yi Hsieh , Sui Xiong Cai , Ye Edward Tian , Lan Liu , Tiantian Niu , Clare Halcro , Baoyue Li , Ning Ma , Congcong Zhang , Xiangna Chen

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Track

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Sub Track

Small Molecules

Clinical Trial Registration Number

NCT04434482

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 3102)

DOI

10.1200/JCO.2022.40.16_suppl.3102

Abstract #

3102

Poster Bd #

94

Abstract Disclosures

Similar Posters

First Author: Junning Cao

Poster

2014 ASCO Annual Meeting

<span>A phase I study of niraparib in combination with temozolomide (TMZ) in patients with advanced cancer</span>.

A phase I study of niraparib in combination with temozolomide (TMZ) in patients with advanced cancer.

First Author: Razelle Kurzrock

First Author: Fei Ma

First Author: Ecaterina Elena Dumbrava